ImmunoVaccine Technologies Appoints New CFO
Immunovaccine Technologies (IVT) announced that it has appointed Gary Dodge, CA, as Chief Financial Officer.
Reporting to president and CEO Dr. Randal Chase, Mr. Dodge will oversee IVT's accounting and financing activities. Mr. Dodge also becomes a part of the company's executive management team, which directs all aspects of company strategy, planning, and operations.
Prior to joining IVT, Mr. Dodge was SolutionInc Technologies Ltd's CFO and was responsible for financial reporting, capital financing, and financial planning. He was also a Director, Transaction Services, for PricewaterhouseCoopers LLP. While working in PwC's Calgary, Johannesburg and Boston offices, Mr. Dodge performed audit and advisory services across many industries, including mergers and acquisitions advisory services to both biotech companies and private equity clients.
Most read news
Other news from the department people
![Newsletter](https://img.chemie.de/assets/bionity/images/newsletter.png)
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.